Ossiam’s Maravai LifeSciences MRVI Stock Holding History

Ossiam’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-4,011	Closed	-$57.4K	–	733
2022 Q4	$57.4K	Hold	4,011	–	–	﹤0.01%	656
2022 Q3	$102K	Buy	+4,011	New	+$101K	﹤0.01%	563

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

Ossiam's MRVI Position: Q1 2023 in Review

Ossiam sold out of Maravai LifeSciences (MRVI) in Q1 2023, closing a stake of 4,011 shares — an estimated $57.4K sold.

Ossiam first reported a position in MRVI in Q3 2022 and held it in 2 quarters. The position peaked at $102K in Q3 2022. 219 funds tracked by Wall St. Rank hold MRVI as of Q1 2023.

Ossiam reported no remaining Maravai LifeSciences position as of Q1 2023 after selling out during the quarter.
Ossiam sold 4,011 Maravai LifeSciences shares in Q1 2023, an estimated $57.4K.
Ossiam first reported a position in Maravai LifeSciences in Q3 2022 and held it in 2 quarters.
Ossiam's Maravai LifeSciences position peaked at $102K in Q3 2022.
219 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2023.

Based on Ossiam's 13F filing for Q1 2023, filed 12 May 2023.